Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.

European heart journal - 1 Nov 2009

Michels Michelle, Soliman Osama I I, Phefferkorn Judith, Hoedemaekers Yvonne M, Kofflard Marcel J, Dooijes Dennis, Majoor-Krakauer Danielle, Ten Cate Folkert J

Abstract excerpt

AIMS: To investigate the outcome of cardiac evaluation and the risk stratification for sudden cardiac death (SCD) in asymptomatic hypertrophic cardiomyopathy (HCM) mutation carriers. METHODS AND RESULTS: Seventy-six HCM mutation carriers from 32 families identified by predictive DNA testing underwent cardiac evaluation including history, examination, electrocardiography, Doppler echocardiography, exercise...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Myosins
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carrier Proteins

Share to Death, Sudden, Cardiac

Share to Genetic Testing

Share to Myosin Heavy Chains

Share to Penetrance

Share to Risk Assessment

Source

Identifiers

PMID: 19666645
DOI: 10.1093/eurheartj/ehp306

Genes

SCD
MYBPC3
MYH7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.PMID 19666645Read ↗

The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.Semantic proximity Read ↗

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.Semantic proximity Read ↗

A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.Semantic proximity Read ↗

Hypertrophic cardiomyopathy: from genetics to treatment.Semantic proximity Read ↗

Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic CardiomyopathySemantic proximity Read ↗

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.Semantic proximity Read ↗

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.Semantic proximity Read ↗

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Predictors for increasing genetic testing yields in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.Semantic proximity Read ↗

Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.